Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,809 | 178 | 95.6% |
| Education | $127.82 | 9 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Radius Health, Inc. | $461.42 | 24 | $0 (2020) |
| PFIZER INC. | $441.51 | 55 | $0 (2020) |
| AbbVie Inc. | $393.23 | 14 | $0 (2020) |
| Lilly USA, LLC | $209.51 | 9 | $0 (2018) |
| TherapeuticsMD, Inc. | $204.86 | 9 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $179.56 | 13 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $121.97 | 8 | $0 (2019) |
| Mylan Pharmaceuticals Inc. | $119.15 | 7 | $0 (2020) |
| Daiichi Sankyo Inc. | $109.30 | 5 | $0 (2019) |
| Novo Nordisk Inc | $93.53 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $285.01 | 17 | TherapeuticsMD, Inc. ($62.63) |
| 2019 | $1,057 | 61 | AbbVie, Inc. ($182.40) |
| 2018 | $993.33 | 59 | Radius Health, Inc. ($255.95) |
| 2017 | $601.34 | 50 | PFIZER INC. ($154.62) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Endocrinology | ||||||
| 03/07/2020 | PFIZER INC. | PREMARIN (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: WOMENS HEALTH | ||||||
| 03/05/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 03/03/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.94 | General |
| Category: Cardiovascular | ||||||
| 03/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.90 | General |
| 02/25/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Obesity | ||||||
| 02/24/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL 9 | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: WOMENS HEALTH | ||||||
| 02/20/2020 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 02/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 02/14/2020 | PFIZER INC. | PREMARIN (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: WOMENS HEALTH | ||||||
| 02/06/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Endocrinology | ||||||
| 02/03/2020 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 01/30/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: WOMENS HEALTH | ||||||
| 01/28/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Obesity | ||||||
| 01/24/2020 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: WOMENS HEALTH | ||||||
| 01/20/2020 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Women's Healthcare | ||||||
| 01/09/2020 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 12/18/2019 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 11/25/2019 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Endocrinology | ||||||
| 11/21/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $102.79 | General |
| Category: Endocrinology | ||||||
| 11/21/2019 | MILLICENT US INC | Femring (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Treat Symptoms of Menopause | ||||||
| 11/20/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Cardiovascular | ||||||
| 11/07/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Anemia | ||||||
| 11/05/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Endocrinology | ||||||
| 10/29/2019 | Hologic, LLC | Aptima Combo 2 (Device), Aptima HPV | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 626 | 655 | $108,800 | $51,802 |
| 2022 | 7 | 634 | 667 | $109,990 | $54,755 |
| 2021 | 10 | 842 | 871 | $134,380 | $69,192 |
| 2020 | 8 | 699 | 728 | $103,360 | $46,700 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 335 | $67,000 | $31,085 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 131 | $17,030 | $8,775 | 51.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 118 | 118 | $9,440 | $5,442 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,700 | $2,350 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,120 | $1,658 | 53.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,990 | $1,612 | 40.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 21 | 21 | $2,520 | $879.27 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 325 | 337 | $67,400 | $33,620 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 138 | $17,940 | $9,179 | 51.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 130 | 130 | $10,400 | $6,126 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,300 | $2,022 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $3,120 | $1,853 | 59.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,150 | $1,351 | 42.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 14 | 14 | $1,680 | $603.57 | 35.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 355 | 365 | $69,720 | $37,103 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 195 | $24,935 | $13,902 | 55.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 157 | 157 | $13,450 | $7,486 | 55.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $7,275 | $3,441 | 47.3% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Facility | 2021 | 11 | 11 | $7,955 | $2,232 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $3,795 | $2,108 | 55.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,395 | $1,461 | 43.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 20 | 20 | $2,040 | $859.60 | 42.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,215 | $440.64 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 53 | 53 | $600.00 | $159.00 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 345 | 354 | $63,720 | $28,001 | 43.9% |
About Dr. Debra Somers, MD
Dr. Debra Somers, MD is a Obstetrics & Gynecology healthcare provider based in Phila, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609850239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Somers, MD has received a total of $2,937 in payments from pharmaceutical and medical device companies, with $285.01 received in 2020. These payments were reported across 187 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,809).
As a Medicare-enrolled provider, Somers has provided services to 2,801 Medicare beneficiaries, totaling 2,921 services with total Medicare billing of $222,448. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecology
- Location Phila, PA
- Active Since 12/06/2005
- Last Updated 01/24/2014
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1609850239
Products in Payments
- Tymlos (Biological) $461.42
- PREMARIN (Drug) $230.49
- FORTEO (Drug) $209.51
- PREMARIN ORALS (Drug) $179.10
- Humira (Biological) $175.17
- Orilissa (Drug) $165.76
- IMVEXXY (Drug) $151.02
- INTRAROSA (Drug) $121.97
- Xulane (Drug) $119.15
- INJECTAFER (Drug) $109.30
- NUVARING (Drug) $94.52
- Femring (Drug) $84.59
- Saxenda (Drug) $76.37
- INTERSTIM (Device) $55.97
- Livalo (Drug) $48.92
- ANNOVERA (Drug) $40.83
- JANUVIA (Drug) $33.28
- PVC (Drug) $31.92
- XARELTO (Drug) $30.82
- XIFAXAN (Drug) $28.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Phila
Dr. Sonya Lee, Md, MD
Obstetrics & Gynecology — Payments: $3,964
Dr. Charna Coren, Md, MD
Obstetrics & Gynecology — Payments: $2,629
Robert Auerbach, Do, DO
Obstetrics & Gynecology — Payments: $1,977
Mark Frisch, Md, MD
Obstetrics & Gynecology — Payments: $1,192
Dr. Bruce Berger, M.d, M.D
Obstetrics & Gynecology — Payments: $265.02
Abegael Lorico, Md, MD
Obstetrics & Gynecology — Payments: $28.25